Watch Ticker

CRISPR Therapeutics AG

Go to CRISPR Therapeutics AG Website

$56.15

-0.11 (-0.20%)

Live

Previous Close

$56.09

Day Range

$53.7 - $56.78

Previous Day Range

$56 - $58.5

Market Cap

$4.8 billion USD

Day Vol.

3.0 million

Previous Day Vol.

3.3 million

Currency

USD

Primary Exchange

Nasdaq

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revol...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Prosper Junior Bakiny - The 3 Things That Matter for Vertex Pharmaceuticals Now

Vertex Pharmaceuticals is a biotech company with a strong focus on cystic fibrosis treatments and expanding into new therapeutic areas like gene-editing, pain management, and type 1 diabetes. The company has multiple promising drug candidates and continues to show potential for significant growth.

Related tickers: VRTX, CRSP.

Read Full Article

Multiple Motley Fool Contributors - 3 Monster Stocks in the Making to Buy Right Now

Three biotech companies - CRISPR Therapeutics, Summit Therapeutics, and Viking Therapeutics - show significant potential for growth in gene editing, cancer treatment, and obesity/metabolic disease markets.

Related tickers: CRSP, SMMT, VKTX, VRTX.

Read Full Article

Trending Tickers

Please sign in to view